Rockefeller Capital Management L.P. Corcept Therapeutics Inc Transaction History

Rockefeller Capital Management L.P.

  • $36 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
SELL
$24.7 - $29.12 $4,767 - $5,620
-193 Reduced 83.55%
38 $0
Q2 2022

Aug 12, 2022
BUY
$17.33 - $25.3 $4,003 - $5,844
231 New
231 $5,000
Q1 2021

May 11, 2021
SELL
$23.49 - $30.56 $117 - $152
-5 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$16.78 - $27.3 $83 - $136
5 New
5 $0

Others Institutions Holding CORT

# of Institutions
403
Shares Held
84.3M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.81B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email